SPECT Imaging Helps Distinguish Depression from Dementia
Overlapping symptoms make it difficult for clinicians to distinguish between depression and a cognitive disorder (CD) such as Alzheimer's disease. Now a new study in the Journal of Alzheimer's Disease shows that single photon emission computed tomography, or SPECT, could distinguish depression from CDs with 86 percent accuracy. In addition, brain SPECT imaging showed the ability to distinguish depression or dementia in people with both with 83 percent accuracy.
See Also: PET Imaging With Tracer Can Detect Early Alzheimer’s
"Cognitive impairment is present in approximately half of persons who have late onset depression and depression is evident in 9-65 percent of individuals with dementia. Studies have indicated that the prevalence of depression in patients with mild cognitive impairment is 25 percent. Consequently, it is often challenging to diagnostically disentangle depression and cognitive disorders from one another," according to the researchers.
In one of the largest studies of its kind, 4,541 subjects were examined, 847 of whom had been diagnosed with dementia, 3,269 with depression, and 425 with both conditions. Using brain SPECT imaging, a nuclear medicine study that measures blood flow and activity, the researchers found that people with cognitive disorders had reduced blood flow in multiple brain areas compared to those with depression, particularly in the hippocampus, temporal, and parietal lobes.
Traditionally, depression can be diagnosed using tools such as the Beck Depression Inventory. However, there was no statistically significant difference in the burden of depression symptoms on this inventory between persons with both depression and CDs compared to persons with either condition. This increases the difficulty of distinguishing these disorders on the basis of depression symptom severity alone.
"These disorders have very different prognoses and treatments and being able to improve diagnostic accuracy can improve outcomes for some patients," explained lead researcher and psychiatrist Daniel G. Amen, MD.
"One of the greatest new insights of the past decade is the linkage of depression to the psychology of late life cognitive decline. Raji and co-workers extend the approach to the biological substrate by an elegant imaging approach. These studies further place brain aging on a firm biological basis," added George Perry, PhD, Editor-in-Chief of the Journal of Alzheimer's Disease and Dean and Professor of Biology University of Texas at San Antonio.
Source: IOS Press
Image Credit: Amen Clinics
Published on : Mon, 20 Feb 2017
Sectra offers solutions for capturing, storing and accessing virtually all images, video, audio and documents. Sectra VNA allows you to consolidate image handling, while ensuring clinical workflow efficiency, growth management and business continuity...
Powered by the most revolutionary ZONE Sonography® Technology, Resona 7’s new ZST+ platform brings the ultrasound image quality to a higher level by zone acquisition and channel data processing. Resona 7 also provides clinical research with the revolutionary...
Introducing a new chapter in ultrasound visualization technology. X-Porte was developed from the ground up to incorporate a breakthrough, proprietary beam-forming technology: XDI (Extreme Definition Imaging). This signal analysis algorithm shapes...
Based on Mindray's new generation ultrasound platform, mQuadro, M9 has raised the industry standards to an all new level. Advanced signal transmission and reception processors provide highly sensitive and accurate echo detection. Innovative transducer...
The Next Evolution in Ultrasound, designed for high expectations ARIETTA 850 ultrasound platform responds to high expectations to answer the ever increasing demands of medical professionals. ARIETTA 850’s fundamental performance has been refined...